New Cholesterol Drugs Mimic Healthy Genomes | GenomeWeb

MIT's Technology Review offers a rundown this week of several pharma projects using the genes of healthy people to inspire new cholesterol-lowering drugs.

Four companies, Pfizer, Amgen, and Alnylam, and a firm called Regeneron, are all developing drugs targeting the gene PCSK9, Tech Review's Susan Young writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

FDA Approved

Best to Work For

Round and Round We Go

Crop's Little Helper

Checking It Out

This Week in Nature

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.